by Rachel Tompa, Stanford University For anyone over the age of 30 reading this article, here’s some bad news for you: Your brain is already on the decline. The good(ish) news? From the brain’s peak performance in our mid-20s, that decline is gradual, said Stanford neurologist Sharon Sha, MD. Despite common lore about aging and...
by Public Library of Science The research suggests that light therapy may be a promising treatment option for patients with Alzheimer’s disease. Credit: Rad Cyrus, Unsplash, CC0 (creativecommons.org/publicdomain/zero/1.0/) Light therapy leads to significant improvements in sleep and psycho-behavioral symptoms for patients with Alzheimer’s disease, according to a new study published in PLOS ONE by Qinghui Meng...
by Cleveland Clinic Credit: CC0 Public DomainCleveland Clinic researchers analyzed genes and brain tissue of patients with Alzheimer’s and found that differences in brain immunometabolism—the interactions between the immune system and the ways cells create energy—may contribute to women’s increased risk for the disease and its severity. The findings, published in Alzheimer’s and Dementia, offer...
Kathrin LaFaver, MD; Meredith Wicklund, MDDISCLOSURES This transcript has been edited for clarity. Kathrin LaFaver, MD: Hi. My name is Kathrin LaFaver. I’m a neurologist in Saratoga Springs, New York. I’ll be talking on behalf of Medscape today with Dr Meredith Wicklund, who is a senior associate consultant and behavioral neurologist specialist at Mayo Clinic...
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON PAUL E. SCHULZ, MD, THE RICK MCCORD PROFESSOR IN NEUROLOGY WITH MCGOVERN MEDICAL SCHOOL AT UTHEALTH HOUSTON, WAS SENIOR AUTHOR OF A STUDY THAT FOUND SEVERAL VACCINATIONS WERE LINKED TO A REDUCED RISK OF ALZHEIMER’S DISEASE. CREDIT: UTHEALTH HOUSTON Prior vaccination against tetanus and diphtheria, with or...
by Josh Meyer, Virginia Tech Credit: Unsplash/CC0 Public Domain Alzheimer’s disease is a progressive neurodegenerative disease estimated to affect 6 million Americans and 33 million people worldwide. Large numbers of those affected have not yet been diagnosed. A new study published in the Journal of Alzheimer’s Disease by a Virginia Tech Carilion School of Medicine faculty member shows...
by University of California – San Diego Systemic transplantation of wild-type hematopoietic stem and progenitor cells (green) led to their differentiation into microglia-like cells (red), which reduced the amount of beta amyloid plaques (magenta) in the brain. Credit: Priyanka Mishra and Alexander Silva, UC San Diego Health Sciences In the ongoing search for a cure for...
by Medical University of South Carolina Dr. del Monte from the Medical University of South Carolina enjoys a break from her research into Alzheimer’s disease and heart failure. Credit: The photo was taken by Sarah Pack from the Medical University of South Carolina. The passing of June’s summer solstice, the longest day of the year, prompts reflection on all of the...
by Sahmyook University Researchers from Korea have now identified phyllodulcin, a major component of hydrangeas, as a potential candidate for the treatment of Alzheimer’s disease. In this animal model study, phyllodulcin controlled the formation and degradation of amyloid aggregates, thereby targeting the main cause of AD. It also reduced memory impairment and improved memory formation processes...
by Perelman School of Medicine at the University of Pennsylvania Individuals with Alzheimer’s disease (AD) have increased neurofibrillary tangles (NFTs) of tau proteins but reduced TRIM11, as shown in the bottom two quadrants, compared to individuals without AD, shown in the top two quadrants. Credit: Penn Medicine A gene encoding a protein linked to tau production—tripartite...
